Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial

JAMA

Volumn 285, Issue 18, 2001, Pages 2331-2338

  Spechler, S J ^a   Lee, E ^a   Ahnen, D ^a   Goyal, R K ^a   Hirano, I ^a   Ramirez, F ^a   Raufman, J P ^a   Sampliner, R ^a   Schnell, T ^a   Sontag, S ^a   Reno Vlahcevic, Z ^a   Young, R ^a   Williford, W ^a  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADENOCARCINOMA; ADULT; ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0035832264     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.18.2331     Document Type: Article

References (46)

1. Gastroesophageal reflux disease
2. Reflux esophagitis: An overview
3. Symptomatic gastroesophageal reflux: Incidence and precipitating factors
4. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
5. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
6. Reflux disease and Barrett's esophagus
7. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
8. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
9. Fire in the belly, money in the bank
10. Antireflux surgery: Indications, preoperative evaluation, and outcome
11. Current status and trends in laparoscopic antireflux surgery: Results of a consensus meeting
12. The rationale for continuous maintenance treatment of reflux esophagitis
13. Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complications
14. The surgical management of Barrett's esophagus
15. Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study
16. Columnar mucosa and intestinal metaplasia of the esophagus: Fifty years of controversy
17. Role of anti-reflux surgery against dysplasia in Barrett's esophagus
18. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus
19. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids
20. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone: The need for surgical therapy re-emphasized
21. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux
22. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia
23. 2 receptor antagonists, and risk of esophageal and gastric cancer
24. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
25. Nissen fundoplication for gastroesophageal reflux disease: Evaluation of primary repair in 100 consecutive patients
26. Value of Nissen fundoplication in patients with gastrooesophageal reflux judged by long-term symptom control
27. Esophageal symptoms, manometry, and histology before and after antireflux surgery: A long-term follow-up study
28. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans
29. Medical and surgical management of reflux esophagitis: A 38-month report of a prospective clinical trial
30. Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: Results of a prospective, randomized clinical trial
31. Development for and the results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial
32. Adenocarcinoma of the oesphagogastric junction
33. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years
34. Barrett's esophagus: Development of dysplasia and adenocarcinoma
35. Barrett's esophagus: Results of a multicentric survey
36. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus
37. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
38. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the Cleveland Clinic Barrett's Esophagus Registry
39. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
40. Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk
41. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
42. Laparoscopic Nissen fundoplication
43. Laparoscopic antireflux surgery: What is real progress?
44. Laparoscopic vs conventional Nissen fundoplication: A prospective randomized study
45. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: Randomised clinical trial
46. Patient satisfaction following laparoscopic and open antireflux surgery